Tenpoint Therapeutics™, a clinical stage biopharmaceutical company, is launching a new era in presbyopia treatment and developing an innovative pipeline targeting the largest areas of unmet need for rejuvenating vision in the aging eye.

Our team is focused on developing groundbreaking treatments for rejuvenating sight in the aging eye. We are developing paradigm-shifting treatments for the largest ophthalmic indications with the greatest need and global market potential: presbyopia, cataracts, and geographic atrophy.